Start Submission Become a Reviewer

Reading: A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure

Download

A- A+
Alt. Display

Case Reports

A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure

Authors:

Vineet S. Gudsoorkar ,

Houston Methodist Hospital, Houston, Texas, US
About Vineet S.
M.D.
X close

Jose A. Perez, Jr.

Houston Methodist Hospital, Houston, Texas, US
About Jose A.
M.D.
X close

Abstract

Synthetic cannabinoids (SCs) are herbal blends that use plant material with varying concentrations of synthetic analogues of cannabinoids. These products are sold as incense or potpourri and are labeled “Not for human use.” Even so, rates of abuse are rapidly increasing worldwide, especially in the young adult population. An extensive network of users exists, and the products can easily be ordered on the Internet under various brand names, including the most popular ones, “K2” and “Spice.” Not much is known about their spectrum of toxicity and no specific antidote is available at present. Renal failure is a rare complication associated with SC abuse.

We describe a case of acute kidney injury associated with use of SCs and present a review of the current literature, including the history and some key pharmacologic and epidemiologic findings related to synthetic cannabinoid compounds.

How to Cite: 1. Gudsoorkar VS, Perez, Jr. JA. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure. Methodist DeBakey Cardiovascular Journal. 2015;11(3):189-191. DOI: http://doi.org/10.14797/mdcj-11-3-189
1
Views
2
Downloads
Published on 01 Jul 2015.
Peer Reviewed

Downloads

  • PDF (EN)